AI Insight
Chimpanzees were historically used in biomedical experiments that led to the identification of the hepatitis C virus in 1989, after the pathogen was artificially injected into them for study purposes. While effective treatments have since been developed that can nearly cure hepatitis C in humans, these same therapeutic interventions have not been provided to the chimpanzees that were used in the original research. The article raises questions about the medical care and treatment of former research animals.
Why it matters
This highlights ethical considerations regarding the ongoing welfare of animals used in past medical research, particularly when treatments developed partly through their use are not extended back to them. It raises broader questions about responsibility toward research animals after experiments conclude and whether they should receive access to therapies their participation helped develop.
Understand the Science
As close relatives of humans, chimpanzees have sometimes been used in biomedical experiments. They were instrumental in the identification of the hepatitis C virus: The then-mysterious pathogen was artificially injected into chimpanzees for study, leading to its eventual identification in 1989. Since then, treatments for humans have advanced, and hepatitis C can now be nearly cured with medication. However, the same treatment has not been extended to chimpanzees.
Source: Treating hepatitis C in chimpanzees used in former medical experiments